(19)
(11) EP 2 240 483 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.04.2013 Bulletin 2013/14

(45) Mention of the grant of the patent:
27.02.2013 Bulletin 2013/09

(21) Application number: 09700747.0

(22) Date of filing: 09.01.2009
(51) International Patent Classification (IPC): 
C07D 471/10(2006.01)
A61K 31/517(2006.01)
A61P 35/00(2006.01)
 C07D 487/10(2006.01)
A61K 31/438(2006.01)
(86) International application number:
PCT/US2009/030603
(87) International publication number:
WO 2009/089454 (16.07.2009 Gazette 2009/29)

(54)

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

PYRIMIDYL-CYCLOPENTANE ALS AKT-PROTEINKINASEHEMMER

PYRIMIDYL CYCLOPENTANES EN TANT QU'INHIBITEURS DE PROTÉINE KINASE AKT

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 09.01.2008 US 20125

(43) Date of publication of application:
20.10.2010 Bulletin 2010/42

(73) Proprietor: Array Biopharma, Inc.
Boulder, CO 80301 (US)

(72) Inventors:
  • BANKA, Anna
    Boulder, Colorado 80301 (US)
  • BENCSIK, Josef R.
    Boulder, Colorado 80301 (US)
  • BLAKE, James F.
    Boulder, Colorado 80301 (US)
  • FONG, Kin Chiu
    Boulder, Colorado 80301 (US)
  • HENTEMANN, Martin F.
    Boulder, Colorado 80301 (US)
  • MITCHELL, Ian S.
    Boulder, Colorado 80301 (US)
  • SAMMOND, Douglas McCord
    Boulder, Colorado 80301 (US)
  • TANG, Tony P.
    Boulder, Colorado 80301 (US)
  • WALLACE, Eli M.
    Boulder, Colorado 80301 (US)
  • XU, Rui
    Boulder, Colorado 80301 (US)
  • GRAHAM, James
    Boulder, Colorado 80301 (US)

(74) Representative: Bailey, Sam Rogerson et al
Mewburn Ellis LLP 33 Gutter Lane
London EC2V 8AS
London EC2V 8AS (GB)


(56) References cited: : 
WO-A-02/22604
 WO-A-2006/090261
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).